Celularity Receives Nasdaq Notice Regarding Form 10-Q
August 22, 2025 17:30 ET | Source: Celularity, Inc. FLORHAM PARK, N.J.,…
Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. (Semnur), and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at $16.0
PALO ALTO, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company…
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2025 16:35 ET | Source: Vor Biopharma CAMBRIDGE, Mass., Aug.…
Youxin Technology Ltd Receives Nasdaq Notifications Regarding Minimum Bid and Market Value of Listed Securities Requirements
Guangzhou, China, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Youxin Technology Ltd (Nasdaq:…
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq ListingRule 5635(c)(4)
August 15, 2025 16:05 ET | Source: X4 Pharmaceuticals BOSTON, Aug. 15,…
Plus Therapeutics Reports Stockholders Equityin Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
August 15, 2025 07:30 ET | Source: Plus Therapeutics Inc. HOUSTON, Aug.…
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 08, 2025 17:00 ET | Source: TELA Bio, Inc. MALVERN, Pa.,…
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 06, 2025 16:45 ET | Source: Neuronetics MALVERN, Pa., Aug. 06,…
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:15 ET | Source: ImageneBio, Inc. SAN DIEGO, Aug.…
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:08 ET | Source: Protara Therapeutics NEW YORK, Aug.…
